CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS is a premier journal published by Cambridge University Press, focusing on significant issues at the intersection of healthcare, ethics, and policy. With an ISSN of 0963-1801 and an E-ISSN of 1469-2147, this journal serves as a vital platform for discourse among researchers, practitioners, and scholars in the health social sciences. Emphasizing vital ethical considerations in healthcare practices and policies, it ranks in the Q3 tier for Health Policy and Q2 for both Health (Social Science) and Issues, Ethics, and Legal Aspects according to the 2023 journal category quartiles. The journal, spanning its tenure from 1992 to 2024, features rigorous peer-reviewed articles that contribute to the advancement of ethical standards in healthcare. By addressing contemporary ethical dilemmas and promoting scholarly dialogue, CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS remains an essential resource for those committed to understanding the complexities and ethical implications inherent in health systems today.

THEORETICAL MEDICINE AND BIOETHICS, published by SPRINGER, is an esteemed journal dedicated to exploring the complex intersections of medicine, ethics, and law. With its ISSN 1386-7415 and E-ISSN 1573-1200, this journal serves as a vital platform for scholars, practitioners, and students interested in the ethical implications of medical practices and innovations. Although it currently holds a Q4 impact factor in the categories of Issues, Ethics and Legal Aspects and Medicine (Miscellaneous) as of 2023, its relevance is amplified by its commitment to fostering critical discourse in a rapidly evolving field. The journal features a diverse range of articles that address profound ethical dilemmas in healthcare, making it a significant resource for contemporary research from 1997 to the present. As an open-access journal, it ensures that cutting-edge knowledge is readily available, inviting contributions that challenge conventional thought and advance the field of bioethics.

BMJ-British Medical Journal, published by the esteemed BMJ PUBLISHING GROUP, is a leading academic journal in the field of medicine, specifically categorized within the top Tier Q1 in Medicine (miscellaneous) based on the 2023 rankings. Recognized for its significant impact, BMJ holds an impressive rank of #15 out of 636 in General Medicine, placing it in the 97th percentile among its peers. With a legacy dating back to 1857, this journal continues to foster critical discussions and disseminate high-quality research aimed at advancing clinical practice and healthcare policy. While currently not an open-access journal, its rigorous peer-review process ensures that every publication meets the highest standards of scientific integrity and relevance. Situated in the heart of London at the British Medical Association House, the BMJ remains an essential resource for researchers, healthcare professionals, and students alike, dedicated to sharing impactful findings and innovative medical insights.

American Journal of Bioethics (ISSN: 1526-5161, E-ISSN: 1536-0075) is a premier publication in the field of bioethics, published by Routledge Journals, Taylor & Francis Ltd, renowned for its commitment to advancing scholarly discourse. Established in 2001, the journal is positioned at the forefront of ethical discussions in healthcare, evidenced by its impressive Q1 rankings in both Health Policy and Issues, Ethics, and Legal Aspects in 2023. With an emphasis on high-impact research, it holds a prestigious Scopus Rank of #1/46 in Nursing and #9/310 in Medicine, showcasing its significance in shaping bioethical considerations. Though not classified as an open access journal, its contents are integral for researchers, practitioners, and students engaged in ethical policymaking and advocacy. By addressing contemporary ethical dilemmas and legal nuances within healthcare, the American Journal of Bioethics serves as an essential resource for fostering an informed dialogue and influencing policy development across the globe.

Monash Bioethics Review, published by SPRINGER HEIDELBERG, is a leading journal in the interdisciplinary realm of bioethics, dedicated to exploring critical issues at the intersection of health policy, philosophy, and the social sciences. With an impressive impact factor placing it in Q1 in Philosophy and notable rankings across disciplines, including Q3 in Health Policy and Medicine, it serves as an essential platform for researchers, professionals, and students alike. This journal not only aims to foster robust discourse on ethical dilemmas but also seeks to contribute to policymaking through rigorous analysis and research. Covering articles from its inception in 1994 to the present, Monash Bioethics Review remains committed to addressing contemporary ethical challenges in medicine and society, making it a vital resource for those keen on navigating the complexities of bioethical thought.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

The International Journal of Chinese & Comparative Philosophy of Medicine, published by GLOBAL SCHOLARLY PUBLICATIONS, is a pivotal scholarly platform dedicated to advancing the discourse around traditional Chinese medicine and comparative philosophies in healthcare. With the ISSN 1386-6354, this journal provides a rich repository of peer-reviewed articles that explore integrative approaches to medicine, addressing both historical context and contemporary applications. Although specific metrics such as impact factor are currently unavailable, it aspires to foster interdisciplinary dialogue among researchers, professionals, and students by encouraging innovative thinking and comparative analysis within the realm of medical philosophy. While currently operating under non-open access guidelines, the journal remains committed to disseminating knowledge that bridges diverse medical practices, making it an invaluable resource for those engaged in the study and application of philosophical medicine.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

BIOETHICS is a leading academic journal published by Wiley, dedicated to exploring the multifaceted issues at the intersection of healthcare, philosophy, and policy. With an ISSN of 0269-9702 and an E-ISSN of 1467-8519, it has established itself as a critical platform for scholarly discourse since its inception in 1987. The journal holds impressive rankings, featuring in the Q1 category in both Health (social science) and Philosophy, alongside a Q2 rating in Health Policy for 2023. This positions BIOETHICS in the top echelons of its fields, ranking 35th out of 806 in Philosophy and garnering high percentiles across relevant disciplines. By fostering a deeper understanding of ethical implications in medical and social contexts, BIOETHICS serves as an essential resource for researchers, professionals, and students committed to addressing contemporary challenges in health and policy. The journal is accessible through institutional subscriptions and offers an engaging platform for the dissemination of significant research findings and theoretical advancements, paving the way for future exploration in bioethical inquiry.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.